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Harboring the behavioral and histopathological signatures of Alzheimer’s disease (AD),
senescence accelerated mouse-prone 8 (SAMP8) mice are currently considered a robust
model for studying AD. However, the underlying mechanisms, prioritized pathways and
genes in SAMP8 mice linked to AD remain unclear. In this study, we provide a biological
interpretation of the molecular underpinnings of SAMP8 mice. Our results were derived
from differentially expressed genes in the hippocampus and cerebral cortex of SAMP8
mice compared to age-matched SAMR1 mice at 2, 6, and 12 months of age using
cDNA microarray analysis. On the basis of PPI, MetaCore and the co-expression network,
we constructed a distinct genetic sub-network in the brains of SAMP8 mice. Next, we
determined that the regulation of synaptic transmission and apoptosis were disrupted
in the brains of SAMP8 mice. We found abnormal gene expression of RAF1, MAPT,
PTGS2, CDKN2A, CAMK2A, NTRK2, AGER, ADRBK1, MCM3AP, and STUB1, which may
have initiated the dysfunction of biological processes in the brains of SAMP8 mice.
Specifically, we found microRNAs, including miR-20a, miR-17, miR-34a, miR-155, miR-18a,
miR-22, miR-26a, miR-101, miR-106b, and miR-125b, that might regulate the expression
of nodes in the sub-network. Taken together, these results provide new insights into the
biological and genetic mechanisms of SAMP8 mice and add an important dimension to our
understanding of the neuro-pathogenesis in SAMP8 mice from a systems perspective.
Keywords: Alzheimer’s disease, senescence accelerated mouse prone 8, molecular network, hippocampus,
cerebral cortex, differential expressed genes, synaptic transmission, apoptosis
INTRODUCTION
Alzheimer’s disease (AD) is a complex neurodegenerative dis-
ease. Despite extensive research, the causal chain of mechanisms
underlying AD remains unknown. Currently, there are no effec-
tive disease-modifying or preventive therapies, and the only
available treatment remains symptomatic to some extent. Studies
aimed at identifying the mechanisms associated with AD and new
therapeutic treatments are currently being performed in rodent
models of AD. Using SAM/resistant-1 (SAMR1) as a control,
the senescence accelerated mouse prone-8 (SAMP8) is a robust
model of AD because it shares phenotypes that resemble the
symptoms of late-onset and age-related sporadic AD patients and
because has distinct advantages over the gene-modified model
(Pang et al., 2006; Pallas et al., 2008;Woodruff-Pak, 2008; Tomobe
and Nomura, 2009; Morley et al., 2012; Pallàs, 2012). Although
investigators have developed new therapies and have tested in
detail, the structural (Gutierrez-Cuesta et al., 2007; del Valle et al.,
2012; Li et al., 2012), functional (Sureda et al., 2006; Tajes et al.,
2008; Lou et al., 2012; Yamaguchi et al., 2012) and behavioral con-
sequences (Gong et al., 2008; Shi et al., 2010b; Shih et al., 2010;
Chang et al., 2012; Kanno et al., 2012; Lopez-Ramos et al., 2012;
Lou et al., 2012; Orejana et al., 2012; Dobarro et al., 2013; Huang
et al., 2013; Sawano et al., 2013) of AD-associated pathology based
on SAMP8 mice, little progress has been made with regard to the
patho-physiological mechanisms of SAMP8 mice, and the under-
lying causes of the AD-like phenotype in SAMP8 mice remain
unknown.
A comprehensive characterization of the biological molecular-
network can provide critical insights into the underlying
mechanisms. Moreover, identification of the biological molecular
pathways may serve as effective targets for therapeutic interven-
tion (Chen et al., 2008; Emilsson et al., 2008; Dobrin et al., 2009;
Zhang et al., 2013). Insights into the patho-physiological mech-
anisms involved in AD are mirrored in the alterations of the
molecular network in the brain (Chen et al., 2008; Emilsson et al.,
2008; Chan et al., 2012; Liang et al., 2012; Satoh, 2012; Furlong,
2013; Zhang et al., 2013). To understand the molecular under-
pinnings of SAMP8 as an AD model and to provide insight into
the underlying molecular mechanisms of AD, we examined the
differentially expressed genes in the hippocampus and cerebral
cortex of SAMP8 compared with SAMR1 mice with age. Next,
we constructed distinct molecular sub-networks based on the
gene expression data and identified numerous functional bio-
logical processes and cellular pathways in the brains of SAMP8
mice. Moreover, we highlighted the remarkable modules that
were dominated by differentially expressed hub genes in SAMP8
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mice. Finally, we identified microRNAs targeting the genes in
the distinct sub-network in the brains of SAMP8 mice. Our
results present a complex multifactorial basis of the underlying
pathophysiology in SAMP8 mice as an AD animal model.
MATERIALS AND METHODS
The study included three procedural modules, including dif-
ferential gene expression assay, network analysis and functional
analysis (Figure 1)
ANIMALS
The original SAMR1 and SAMP8 mice were kindly provided by
Dr. T. Takeda at Kyoto University (Kyoto, Japan) and housed at
the Beijing Institute of Pharmacology and Toxicology under a
natural light-dark cycle (12 h light:12 h dark), room temperature
(25 ± 1◦C), and normal relative humidity (50 ± 5%). Food and
water were provided ad libitum. Two-, six- and twelve-month-old
male SAMP8 and SAMR1 mice were used. Each group (n = 6)
was sacrificed by decapitation, and their brains were removed and
placed on ice before dissection of the hippocampus and cerebral
cortex. Animal care and experimental procedures were performed
according to the guide for the Care and Use of Laboratory
Animals as adopted by the United States National Institutes of
Health.
DIFFERENTIAL GENE EXPRESSION ASSAY USING cDNA MICROARRAY
A gene expression assay were performed according to previously
described methods (Cheng et al., 2007a,b; Zheng et al., 2008).
Briefly as follows:
Total RNA was purified from the hippocampus and cerebral
cortex of each group using TRIZOL reagent (Invitrogen Cat. No.
15596-026). The integrity of the total RNA was detected using
agarose gel, and the purity and concentration were determined
using the spectrophotometer (NanoDrop, ND-1000).
Fifty micrograms of total RNA were used for reverse tran-
scription according to standard protocols using SUPERSCRIPT
FIGURE 1 | The scheme of analysis procedure. The procedure includes
three steps. Firstly differential expressed genes in the hippocampus and
cerebral cortex of SAMP8 mice comparing with age-matched SAMR1 mice at
the age of 2, 6, and 12 months were identified utilizing the cDNA microarray
technique. Then, we inferred three sub-networks based on PPI, MetaCore
and co-expression network, respectively. Distinct network modules and
nodes were identified based on the three sub-networks. For each
sub-network and module, GO and KEGG pathway enrichment were achieved
employing DAVID. Finally, miRNAs potentially involved in AD-like phenotype in
SAMP8 mice were analyzed using experimental validated miRNA target data.
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III reverse transcriptase (Invitrogen Cat. No. 18080-044) and aa-
dUTP (Amersham Pharamacia Biotech). Subsequently, aa-cDNA
first strand was purified using the QIAquick PCR purification kit
(QIAGEN Cat. No. 28104).
The purified aa-dUTP of the control and treated groups
were labeled using cy5 or cy3 monofunctional dye (Amersham
Pharamacia Biotech), respectively. The corresponding fluores-
cently labeled cy3 and cy5 cDNA were combined and purified
using the MinEluteTM Reaction Cleanup Kit (QIAGEN Cat. No.
28204) and lyophilized in the nucleic dryer (SPD1010 SpeedVac).
The amino groups on the spotted slide (Cheng et al.,
2007b) were blocked at room temperature by washing with
NaBH4/PBS/ethanol. Prehybridization in the hybridization box
was performed for 1 h at 42◦C, and then plated with buffer con-
taining 5× SSC, 0.1% SDS, 1% BSA under glass coverslips in the
hybridization chamber (Robbins Scientific Co.).
After pre-hybridization, the slides were washed and dried
immediately. The dried fluorescently labeled cDNA was resolved
in 15μL hybridization buffer, denatured at 98◦C for 5min
and centrifuged at 12,000 rpm for 5min; the entire supernatant
was then pipetted and spread onto the slide. The hybridization
procedure was the same as the pre-hybridization procedure except
for the 18 h hybridization time. Subsequently, the slides were
washed and dried immediately.
The hybridized array was scanned and analyzed using the
GenePix 4100Amicroarray scanner (Axon Instruments Inc.) and
GenePix Pro 5.1 software (Axon Instruments Inc.), which was
combined using Microsoft Excel software. Statistical analyses of
each remaining gene on six replicate microarray slides for the
experimental repetatur was implemented using SAM software
(significance analysis microarray, Stanford University) with one
class mode (δ = 0.96938). The absolute value of fold change in
gene expression exceeding 1.6 was considered a significant change
in expression.
NETWORK INFERENCE PROCEDURE
We employed three types of biological networks to infer the
most relevant sub-networks in the SAMP8 mice as an AD model,
including the background networks; protein-protein interaction
(PPI) network, co-expression network and MetaCore network.
Protein-protein interaction network analysis
The protein-protein interaction network (PPI) is modeled as an
undirected graph with nodes representing the genes, and the
edges representing the physical or binding interactions between
the proteins encoded by the genes. First, we downloaded the back-
ground networks from the Human Protein Reference Database
(HPRD, www.hprd.org), containing 9673 proteins and 39,240
interactions (Human Protein Reference Database-2009 update,
release 9). Next, to investigate the sub-network in the brains of
SAMP8 mice, we employed the algorithm proposed by Alexey
et al. (Antonov et al., 2009). In detail, usingMATLAB software, we
referred to the input gene lists, which were differentially expressed
genes in the brains of SAMP8 in the present study, as seed genes,
and these seed genes were mapped onto the PPI network. The
distance between any two seed genes was calculated. Specifically,
this distance indicated the minimal number of consecutive steps
from one seed gene to another. For example, a distance of 1 indi-
cated that two seed genes were connected directly, and a distance
of 2 indicated that two seed genes were separated by a non-
seed gene (known as the intermediate gene). The sub-network in
SAMP8 consisted of seed genes whose distance was less than 3,
intermediate genes, and their edges (Supplement Figure 1).
Metacore network analysis
MetaCore is commercially available software (Thompson Reuters,
New York, NY) used for the functional analysis of high through-
put data. MetaCore provides the known molecular interactions
and pathways curated manually from published papers. We sub-
mitted the differentially expressed genes in SAMP8 mice in the
present study to MetaCore (https://portal.genego.com, released
at August 29, 2012). To obtain a comparatively complete back-
ground network for SAMP8 mice, we developed a network
employing the differentially expressed genes as seed genes using
a different algorithm (shortest path, analysis network, transcript
regulation), and integrated these networks according to MATLAB
script. The sub-network inference procedure of the MetaCore
network in the brains of SAMP8 mice was the same as the PPI
network (Supplement Figure 1).
Co-expression network analysis
The co-expression network is a phenotypic network based
on transcriptional patterns. The human co-expression network
was downloaded from COXPRESdb (Obayashi and Kinoshita,
2011) version c4.0, which was released on August 29, 2012
(http://coxpresdb.jp). We selected gene pairs with significant co-
expression patterns whose correlation coefficient was equal to or
greater than 0.5, and the reserved interactions were used as the
background co-expression network. The sub-network inference
procedure of the co-expression network in the brains of SAMP8
mice is the same as the PPI network (Supplement Figure 1).
ANALYSIS OF FUNCTIONAL CATEGORIES IN THE NETWORK
Distinct network module and nodes analysis
Using MATLAB software, we identified the hub seed genes and
key modules in the brains of SAMP8 mice. The seed genes were
differentially expressed in SAMP8 mice in the present study. For
each of the PPI, co-expression, or MetaCore sub-network, seed
genes withmore than 14 direct interacting neighbors were defined
as hub seed genes. These hub seed genes and their direct interac-
tions formed the key module in each of the PPI, co-expression, or
MetaCore sub-network.
GO and KEGG pathway enrichment analysis
For the biological and functional annotation of the genes
within each PPI, co-expression, or MetaCore sub-network
in the brains of SAMP8 mice, Gene Ontology (GO) analy-
sis and Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway enrichment were performed using the Database for
Annotation, Visualization and Integrated Discovery (DAVID)
(http://david.abcc.ncifcrf.gov/) (Huang da et al., 2009a,b). Using
DAVID-based analyses, the reported P-values were derived from
the Expression Analysis Systematic Explorer (EASE) score prob-
ability, which is a modified version of the Fisher’s exact test.
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The significance of the overrepresentation was adjusted for mul-
tiple comparisons to control for the false discovery rate (FDR)
using the approximated FDR tools provided in DAVID. The GO
Biological Processes (BPs), highest-level terms in the BP Gograph
structure, and KEGG pathways with P < 10−3 and FDR <0.01
were considered to be a specific function and biological pathway
of genes in the PPI, co-expression, or MetaCore sub-network, and
modules in the brains of SAMP8 mice.
Microrna targeted genes in the sub-network
To identify microRNAs involved in the AD-like phenotype of
SAMP8 mice, we obtained 3923 miRNA-target pairs from four
validated miRNA target databases updated on April 16, 2013,
including Tarbase (http://www.diana.pcbi.upenn.edu/tarbase)
(Sethupathy et al., 2006), miR2disease (http://www.miR2Disease.
org) (Jiang et al., 2009), miRecords (http://miRecords.umn.
edu/miRecords) (Xiao et al., 2009a), and miRtarbase (http://
miRTarBase.mbc.nctu.edu.tw) (Hsu et al., 2011). These miRNA-
target pairs were used to construct the miRNA-gene bipartite
graph network in SAMP8 mice. There are two types of vertices in
this bipartite graph network. One vertex represents genes in the
PPI, co-expression, and the MetaCore sub-network in the brains
of SAMP8, and the other vertex represents the miRNAs targeting
these genes.
RESULTS
ALTERATIONS IN GENE EXPRESSION IN THE HIPPOCAMPUS AND
CEREBRAL CORTEX OF SAMP8 MICE
Differentially expressed mRNA in the hippocampus and cerebral
cortex of SAMP8 and SAMR1 mice at 2, 6, and 12 months were
investigated using cDNA microarray (Cheng et al., 2007b). We
found that the gene expression profile in the hippocampus of
SAMP8 mice were different from SAMR1 mice at three different
ages (Table 1). In the hippocampus, there were 42 differentially
expressed genes in SAMP8 mice compared with SAMR1 mice at
the age of two months, 12 genes at six months, and 57 genes at
twelve months [parts of the data in 12-month-old mice have been
published in 2007 (Cheng et al., 2007b)]. In the cerebral cortex,
Table 1 | Differentially expressed genes in the hippocampus of SAMP8 and SAMR1 mice with aging*.
2-month-old 6-month-old 12-month-old
Gene symbol Ratio of P8 Gene symbol Ratio of P8 Gene symbol Ratio of P8 Gene symbol Ratio of P8 Gene symbol Ratio of P8
to R1 to R1 to R1 to R1 to R1
Amfr 1.98 Sympk −1.88 Penk1 2.70 Dnchc1 8.51 Rock1 1.71
Fhit −1.62 Mink1 −1.88 Uqcr 1.94 ARNT2 3.24 Olfr273 1.70
Ercc5 −1.63 Trim3 −1.88 Slc17a7 1.85 Rps21 2.97 Thyn1 1.69
Mast2 −1.66 Dnahc8 −1.93 Ssu72 1.82 Rcn 2 2.81 Vps13c 1.52
Dip3b −1.68 Dusp12 −1.99 Prr6 1.79 Tspan2 2.57 Ager −1.59
KDELR1 −1.68 Vps13c −2.01 Tmem186 1.67 UQCRFS1 2.32 ZNF133 −1.64
Syde1 −1.68 Ticam2 −2.01 MTCO1 1.67 MTCO1 2.28 GANP −1.66
Ankzf1 −1.71 B3gat1 −2.06 Ankzf1 1.62 Cstn1 2.26 Cdkn2a −1.68
STUB1 −1.72 NSF −2.10 DUSP12 1.62 Raf1 2.22 Olfr272 −1.69
Kcns2 −1.74 Acrbp −2.13 Rps6ka1 −1.60 Kinectin 2.21 cox2 −1.72
Strn4 −1.75 Ihpk1 −2.15 cox2 −1.72 ZNF 238 2.14 Bbox1 −1.73
Thyn1 −1.76 Samm50 −2.15 Ttc3 −2.36 Epha4 2.12 Fyco1 −1.80
Def8 −1.81 Tmem186 −2.19 Kcnh6 2.12 DUSP12 −1.84
Rcn2 −1.81 Olfr272 −2.21 Map3k3 2.12 Ankzf1 −1.85
C1qb −1.82 Gm11502 −2.23 NF-L 2.11 NSF −1.87
Prr6 −1.84 Kcnh6 −2.25 ADRBK1 2.09 RAB26 −1.91
Rab26 −1.84 Cpsf3l −2.25 Eph B6 2.06 Ttc3 −1.91
Sec23b −1.86 Ttc3 −2.36 Fin14 1.97 Map4k6-pending −1.96
MTCO1 −1.87 Uqcr −2.50 Ticam2 1.96 Cacng4 −2.00
Ranbp5 −1.87 Ddx3x −2.53 Uqcr 1.94 Mapt −2.01
Snx27 −1.87 Oxr1 −2.58 KDELR1 1.92 Fhit −2.03
Ntrk2 1.92 Strn4 −2.07
Snx27 1.87 Rps19bp1 −2.09
Tmem186 1.85 NRXN1 −2.17
Gm11502 1.84 RNase H −2.74
Rpl26 1.84 STUB1 −3.14
Mast2 1.82 Sympk −3.45
MTCO3 1.75 CAMK2α −24.51
Kpnb3 1.72
*The fold change of gene expression is greater than 1.6 is considered significant; “+” means up-regulated expression; “−” means down-regulated expression.
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the gene expression profile in SAMP8 mice was different from
SAMR1 mice at only two different ages (Table 2). There were 18
and 32 differentially expressed genes in SAMP8 mice compared
with SAMR1 mice at 6 and 12 months of age, respectively, with
only one difference present at the age of two months.
THE DISTINCT GENETIC SUB-NETWORK IN THE BRAINS OF
SAMP8 MICE
Sub-network based on the PPI network
There were a total of 81 unique differentially expressed genes in
the hippocampus and cerebral cortex in SAMP8 mice, including
78 genes in the hippocampus and 37 genes in the cerebral cortex.
Using differentially expressed genes in the hippocampus and cere-
bral cortex, we independently identified the PPI sub-networks of
two tissues (Supplement Figure 2A for hippocampus and 2B for
cerebral cortex). After constructing the tissue-specific PPI sub-
network, we used 81 differentially expressed genes as seed genes
to identify the PPI sub-network in SAMP8 mice. These results
showed that the sub-network of the hippocampus and cerebral
cortex inferred from PPI contained 105 genes, in which 25 genes
were AD-related according to AlzGene (http://www.alzgene.org,
April 18, 2013) (Bertram et al., 2007) and the p-value was 3.744E-
14 (fisher exact test) (Figure 2) (Supplement Table 2). Detailed
topological information of the sub-networks is provided in the
Supplementary materials (Supplement Table 1). Enriched GO
terms included the regulation of apoptosis, synaptic transmis-
sion, cellular protein complex assembly, protein kinase activity
Table 2 | Differentially expressed genes in the cerebral cortex of
SAMP8 and SAMR1 with aging∗.
6-month-old 12-month-old
Gene Ratio of P8 Gene Ratio of P8 Gene Ratio of P8
symbol to R1 symbol to R1 symbol to R1
pol 2.61 Ihpk1 −1.64 Dusp12 −1.88
Uqcr 1.97 Vps13c −1.65 Oxr1 −1.89
Tmem186 1.93 Mast2 −1.66 Nsf −1.92
Ticam2 1.92 Ngrn −1.66 Samm50 −1.93
cox2 1.87 Def8 −1.69 Trim3 −1.96
Gm11502 1.73 Phb −1.71 Amfr −1.97
C1qb 1.72 C1qb −1.71 Ttc3 −1.98
Rab26 1.71 Kcns2 −1.71 Kcnh6 −2.03
Clstn1 1.68 Sec23b −1.73 Uqcr −2.08
Dusp12 1.68 Acrbp −1.74 NRXN1 −2.10
Trim3 1.67 Rcn2 −1.75 Gm11502 −2.11
Def8 1.66 Sympk −1.76 cox2 −2.17
Ihpk1 1.65 Kdelr1 −1.77 Ticam2 −2.19
Ttc3 1.61 Ankzf1 −1.79 Tmem186 −2.29
Vps13c 1.60 Rock1 −1.81
Slc17a7 −2.13 Prr6 −1.81
Rn18s −2.21 Fhit −1.83
Rps6ka1 −2.27 Syde1 −1.86
*The fold change of gene expression is greater than 1.6 is considered significant;
“+” means up-regulated expression; “−” means down-regulated expression;
there was no difference at the age of two months.
and neuron projection morphogenesis (Figure 5) (Supplement
Table 5). However, the neurotrophin signaling pathway, pathways
in cancer, MAPK signaling pathway, GnRH signaling pathway,
cell cycle, ErbB signaling pathway, oocyte meiosis, adherens junc-
tion, long-term potentiation (LTP), AD, focal adhesion, and
vascular smooth muscle contraction were enriched (Figure 5)
(Supplement Table 5).
Sub-network based on the MetaCore network
We submitted the differentially expressed genes in SAMP8 to
MetaCore, and the independent sub-networks of hippocampus
and cerebral cortex were derived using the MetaCore network
as the background network (Supplement Figure 3A for hip-
pocampus and 3B for cerebral cortex). The sub-network for the
two tissues contained 213 genes, 40 of which were AD-related
(Bertram et al., 2007), and the p-value was 2.2 e16 (Fisher’s exact
test) (Figure 3) (Supplement Table 3). Detailed topological infor-
mation of this sub-network based on MetaCore is provided in
the Supplementary materials (Supplement Table 1). Enriched GO
terms included the regulation of apoptosis, regulation of synap-
tic transmission, protein import into nucleus and regulation of
the glucose metabolic process (Figure 5) (Supplement Table 5).
The KEGG pathways were enriched, including pathways in cancer,
the MAPK signaling pathway, neurotrophin signaling pathway,
GnRH signaling pathway, Wnt signaling pathway, ErbB signaling
pathway, Focal adhesion, TGF-beta signaling pathway, adherens
junction, LTP, B cell receptor signaling pathway, chemokine sig-
naling pathway, cell cycle, Toll-like receptor signaling pathway,
and the T cell receptor signaling pathway (Figure 5) (Supplement
Table 5).
Sub-network based on the co-expression network
According to the sub-network inference procedure described in
the PPI network, we derived sub-networks of the hippocam-
pus, cerebral cortex, hippocampus and cerebral cortex using gene
pairs with significant co-expression patterns whose correlation
coefficient was equal to or greater than 0.5 as the background co-
expression network. Independent sub-networks of the hippocam-
pus and cerebral cortex in SAMP8 mice were derived (shown
in Supplement Figure 4A for hippocampus and 4B for cerebral
cortex). The sub-network for two tissues contained 197 genes,
7 of which were AD-related (Bertram et al., 2007) (Figure 4)
(Supplement Table 4). Detailed topological information of the
sub-network in SAMP8 mice based on the co-expression network
is provided in the Supplementary materials (Supplement Table
1). The ATP synthesis coupled electron transport was enriched
using GO terms (Figure 5) (Supplement Table 5). KEGG path-
ways were enriched, including those involved in Huntington’s
disease, Parkinson’s disease, oxidative phosphorylation and AD
(Figure 5) (Supplement Table 5).
The remarkable biological processes and pathways in the brains of
SAMP8 mice
To investigate the specific function and biological pathway of
genes in the PPI, co-expression, and MetaCore sub-network in
the brains of SAMP8 mice as an AD animal model, the GO
functional annotation and pathway enrichment analysis were per-
formed using the online tool DAVID. Of the biological processes,
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FIGURE 2 | The distinct genetic sub-network of hippocampus and
cerebral cortex in SAMP8 mice based on PPI network. Red nodes
represent differential expressed genes in SAMP8 mice, green nodes are
intermediate genes, and genes marked with blue circle are AD-related. The
size of the node corresponds to the number of its direct neighbors. The
nodes are linked if they have interaction in PPI network.
only the regulation of synaptic transmission and apoptosis was
presented in two types of sub-networks in SAMP8 mice at the
same time (Figure 5) (Supplement Table 5). This indicated that
these two processes are remarkable and might play an important
role in the underlying mechanism associated with the AD-like
phenotype in SAMP8 mice.
The results of the pathway enrichment analysis showed that
in twenty-one cellular pathways, LTP, MAPK signaling path-
way, GnRH signaling pathway, ErbB signaling pathway, adherens
junction, focal adhesion, cell cycle, pathways in cancer and AD
appeared in the PPI and MetaCore or PPI and co-expression sub-
network in the brains of SAMP8 mice at the same time (Figure 5)
(Supplement Table 5). This indicated that these nine pathways
were significant and might contribute to the share cognitive per-
formance and histopathological and biochemical characteristics
of AD in SAMP8 mice.
SIGNIFICANT MODULES AND NODES OF THE GENETIC SUB-NETWORK
IN THE BRAINS OF SAMP8 MICE
Using MATLAB software, we identified 10 hub seed genes with
more than 14 direct interacting neighbors in the PPI, co-
expression, or MetaCore sub-network in the brains of SAMP8,
and found 10 modules consisting of hub seed genes and their
direct interactions (Figure 6) (Supplement Table 6). These 10
hub seed genes are remarkable nodes in the brains of SAMP8
mice, and include RAF1, MAPT, PTGS2, CDKN2A, CAMK2A,
NTRK2, AGER, ADRBK1, MCM3AP and STUB1. The hub nodes
of the significant modules m1, m2, m3, m5, m6, and m8 are
RAF1, MAPT, PTGS2, CAMK2A, NTRK2, and ADRBK1, respec-
tively, and the hub nodes of m4, m9 and m10 are CDKN2A,
MCM3AP, and STUB1, respectively. The hub node of m7 is
AGER. This result showed that the abnormal expression of RAF1,
MAPT, PTGS2, CDKN2A, CAMK2A, NTRK2, AGER, ADRBK1,
MCM3AP, and STUB1 might be involved in the structural, func-
tional, and behavioral consequences of AD-associated pathology
in SAMP8 mice.
GO functional annotation and KEGG pathway enrichment
analysis were performed for eachmodule using DAVID.We found
thatmodulem1 andm2were significantly associated with the reg-
ulation of apoptosis, and m3, m4, m5 and m7 were associated
with the regulation of transcription. In addition, m6, m8, m9,
and m10 were associated with cell motion, cellular ion homeosta-
sis, pathways in cancer, and the regulation of biosynthetic process,
respectively (Figure 6) (Supplement Tables 6, 7). We highlighted
the contribution of the regulation of apoptosis and synaptic trans-
mission in the AD-like phenotype of SAMP8 mice because there
were at least five modules that were related to these three bio-
logical processes (Figure 7) (Supplement Table 7). This indicated
that RAF1, MAPT, PTGS2, CDKN2A, CAMK2A, NTRK2, AGER,
ADRBK1, MCM3AP, and STUB1 might induce SAMP8 mice to
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FIGURE 3 | The distinct genetic sub-network of hippocampus and
cerebral cortex in SAMP8 mice based on MetaCore network.
Red nodes represent differential expressed genes in SAMP8 mice,
green nodes are intermediate genes, and genes marked with blue
board are AD-related. The size of the node corresponds to the
number of its direct neighbors. The nodes are linked if they
have interaction in MetaCore. The red line with black arrow
indicates activation. The blue line with black small line segments
indicates inhibition. The blue line indicates there is undefined
interaction between nodes.
demonstrate patho-physiological hallmarks of AD by regulating
apoptosis and synaptic transmission.
For KEGG pathway enrichment, pathways in cancer, MAPK
signaling pathway, GnRH signaling pathway, and LTP are the
top four pathways. In addition, the neurotrophin signaling path-
way, Wnt pathway, TGF-beta signaling pathway, adherens junc-
tion, gap junction, vascular smooth muscle contraction, cell
cycle, and ErbB signaling pathway were enriched in two mod-
ules (Figure 7) (Supplement Table 7). This finding indicated
that RAF1, MAPT, PTGS2, CDKN2A, CAMK2A, NTRK2, AGER,
ADRBK1, MCM3AP, and STUB1 might mainly target these 12
pathways, resulting in the typical symptoms of AD observed in
SAMP8 mice.
MicroRNAs TARGETING THE NODES OF THE GENETIC SUB-NETWORK
IN THE BRAINS OF SAMP8 MICE
To identify the microRNAs regulating the expression of nodes
in the genetic sub-network in the brain of SAMP8 mice, we
derived the miRNA-gene bipartite graph network employing
four validated miRNA target databases, including the Tarbase,
miR2disease, miRecords, and miRtarbase. This miRNA-gene
bipartite graph network contained 101 genes, 9 of which were dif-
ferential expression in SAMP8 mice (Figure 8) (Supplementary
Table 8).
The miRNA-gene bipartite graph network in the brains of
SAMP8 mice contained 137 miRNAs. These microRNAs regu-
lated the expression of nodes in the genetic sub-network in the
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FIGURE 4 | The distinct genetic sub-network of hippocampus and
cerebral cortex in SAMP8 mice based on co-expression network. Red
nodes represent differential expressed genes in SAMP8 mice, green nodes
are intermediate genes, and genes marked with blue board are AD-related.
The size of the node corresponds to the number of its direct neighbors. The
nodes are linked if they are significantly co-expressed.
brains of SAMP8mice. The top 10miRNAs with P ≤ 8.37 e5 were
listed in Table 3. They are miR-20a, miR-17, miR-34a, miR-155,
miR-18a, miR-22, miR-26a, miR-101, miR-106b, and miR-125b,
indicating that these ten miRNAs could regulate the expression
of nodes (genes) in the sub-network of SAMP8 mice and might
be one cause inducing SAMP8 mice to exhibit significant nodes
(or genes) and to display a distinct genetic sub-network in the
brain.
DISCUSSION
It is well known that AD is a complex disease and devastating
neurodegenerative disorder without effective disease-modifying
or preventive therapies. Its progression in late-onset AD stud-
ies is fundamentally limited by our reliance on mouse models of
severe familial/early-onset AD (Zhang et al., 2013). SAMP8 mice,
a spontaneous animal model of accelerated aging and harboring
the behavioral and histopathological signatures of AD, may more
closely represent the complexity of the disease compared to the
gene-modifiedmodel due to its multifactorial nature of late-onset
or age-related sporadic AD (Pang et al., 2006; Pallas et al., 2008;
Woodruff-Pak, 2008; Tomobe and Nomura, 2009; Morley et al.,
2012; Pallàs, 2012). Thus, understanding the underpinnings of
the AD-like phenotype in SAMP8 mice is essential for developing
and evaluating therapeutic approaches for this widespread and
devastating insidious disease. A comprehensive characterization
of gene-network connectivity and its regulation and association
to disease can provide critical insights into the underlying mech-
anisms, highlight and prioritize pathways, and identify genes
and microRNAs that may serve as effective targets for thera-
peutic intervention (Furlong, 2013; Gandy and Heppner, 2013;
Jahanshad et al., 2013; Rhinn et al., 2013; Zhang et al., 2013). The
present study identified the sub-network, bioprocesses, pathways,
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FIGURE 5 | The remarkable biological processes and pathways in the brain of SAMP8 mice. GO functional annotation (left) and KEGG pathway
enrichment (right) of PPI, co-expression and MetaCore sub-networks.
FIGURE 6 | The significant modules and nodes of genetic
sub-network in the brain of SAMP8 mice. Red nodes are differential
expressed genes in SAMP8 mice, and green nodes are intermediate
genes. The genes are linked with red line if they have interaction in
MetaCore, green line if they have interaction in PPI, and blue line if
they are significant co-expressed. The red line with black arrow
indicates activation. The red line with black small line segments
indicates inhibition.
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FIGURE 7 | The function of significant modules and nodes of genetic
sub-network in the brain of SAMP8 mice. GO functional annotation
(left) and KEGG pathway enrichment (right) of 10 modules. Red
rectangle nodes are modules, and blue round nodes are GO terms and
KEGG pathways, respectively. The size of the node corresponds to its
direct neighbors.
genes and miRNAs in SAMP8 mice employing approaches
in network biology, and offered valuable insights for the
patho-physiological molecular mechanisms and drug targets or
treatments of AD.
THE DISTINCT SUB-NETWORK IN THE BRAINS OF SAMP8 MICE
Although a number of alterations in gene expression and pro-
tein abnormalities studies have been performed on SAMP8 mice
(Butterfield and Poon, 2005; Carter et al., 2005), no clear pic-
ture has emerged on the underlying mechanisms, prioritized
pathways and genes in SAMP8 mice linked to AD. With the
development of the molecular network analysis method, there
have been few progress obtained. For example, using proteomics
and network analyses, 17 neuronal and 14 astrocytic differen-
tially expressed proteins in SAMP8mice were found, and network
analysis suggested that the neuronal changes were more com-
plex and had a greater influence (Diez-Vives et al., 2009). In the
present study, using three different network analysis methods, we
constructed a genetic sub-network using differentially expressed
genes in the hippocampus and cerebral cortex of SAMP8 com-
pared with SAMR1 at the age of 2, 6, and 12 months. Based on
this sub-network, the underlying mechanisms, prioritized path-
ways and genes have been identified in SAMP8 mice as an AD
model.
REMARKABLE BIOLOGICAL PROCESSES IN THE BRAINS OF
SAMP8 MICE
In the present study, based on sub-network analysis, biologi-
cal processes including the regulation of synaptic transmission
and apoptosis were identified as disrupted in the brains of
SAMP8 mice (Figure 5). This finding suggested that the aber-
rations in the synaptic transmission and apoptosis may be
the underlying mechanism of SAMP8 mice as an AD animal
model.
Our previous study demonstrated that the glutamatergic
synaptic transmission was weakened in the brains of SAMP8mice
owing to the low protein expression level of vesicular glutamate
transporter1 (VGLUT1), a specific marker for glutamatergic neu-
rons, and synaptophysin (Syp), a marker of the synapse (Cheng
et al., 2011). Moreover, there were aberrations in morphologi-
cal synaptic plasticity, including a reduction in the number of
apical dendritic thorns, abnormal ultrastructure of excitatory
synapses, and a decrease in the expression of GluN1 subunit-
containing N-methyl-d-aspartate receptors (NMDARs) and Syn
in the hippocampus of SAMP8 mice (Li et al., 2013). In addi-
tion, the protein levels of the three representative proteins of
synaptic function and synaptic structure, including brain-derived
neurotrophic factor (BDNF), post-synaptic density protein-
95 (PSD95) and Ca2+/calmodulin-dependent protein kinase II
(CaMKII) in SAMP8 mice were lower compared to the SAMR1
mice (Li et al., 2009). These results indicated that the aberra-
tions in synaptic transmission emerged in the brains of SAMP8
mice.
For the regulation of apoptosis, there were significant levels of
neuronal apoptosis were observed in the hippocampus of SAMP8
mice, which was comparable with those in the SMAR1 mice (Ma
et al., 2011; Lou et al., 2012). The number of hippocampal neu-
rons was decreased in the hippocampus of SAMP8 mice (Yaguchi
et al., 2010; Hu et al., 2012), and there was an increase in the
number of condensed nuclei in primary culture cerebellar neu-
rons from SAMP8 mice (Tajes et al., 2008). Furthermore, there
was an age-related significant increase in apoptosis in the medial
neocerebellum and vermis, and some Purkinje cells appeared to
disappear during aging in SAMP8 mice (Zhu et al., 2007).
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FIGURE 8 | MicroRNAs targeting on nodes of genetic sub-network
in the brain of SAMP8 mice. In this miRNA-gene bipartite graph
network, round nodes represent genes in the PPI, co-expression,
and MetaCore sub-network in the brain of SAMP8, blue round
nodes are differential expressed genes in SAMP8 mice, and green
round nodes are intermediate genes. Red triangle nodes represent
miRNAs targeting on these genes. The links represent validated
target interactions.
THE EXTRAORDINARY CELLULAR PATHWAYS IN THE BRAINS OF
SAMP8 MICE
The present study clearly showed that the SAMP8 mice involved
a dysfunction of many cellular pathways, including LTP, focal
adhesion, MAPK signaling pathway (Xiao et al., 2009b), GnRH
signaling pathway (Yuan et al., 2005), ErbB signaling pathway,
adherens junction (Ueno et al., 2001), cell cycle (Casadesus et al.,
2012) and pathways in cancer (Gutierrez-Cuesta et al., 2008)
(Figure 5). Genes in the distinct sub-network of the SAMP8
mice might mainly target on these cellar pathways to induce the
malfunction of these biological process. Six pathways have been
previously reported except for the ErbB signaling pathway and
focal adhesion.
For LTP, our previous study showed that the LTP in the CA1
area of hippocampal slices prepared from 2-, 6-, and 12-month-
old SAMP8mice had significantly decreased with age. In addition,
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Table 3 | The top ten microRNAs targeting on nodes of genetic
sub-network in the brain of SAMP8 mice.
miRNA Number of targets in miRNA- P-value
gene bigraph network
miR-20a 9 8.16E-09
miR-17 10 1.30E-07
miR-34a 9 2.78E-07
miR-155 14 2.16E-07
miR-18a 5 4.04E-06
miR-22 5 6.18E-06
miR-26a 6 9.29E-06
miR-101 5 3.30E-05
miR-106b 5 3.30E-05
miR-125b 8 8.37E-05
LTP in the slices of 6- and 12-month-old mice was markedly
decreased below that of the age-matched normal SAMR1 mouse
strain (Yang et al., 2005; Hu et al., 2012; Huang et al., 2012).
Lopez-Ramos et al. demonstrated that SAMP8 mice presented a
significant deficit in LTP at the CA1-medial prefrontal synapse at
5 months of age (Lopez-Ramos et al., 2012). LTP, a well-known
form of synaptic plasticity, is the neuronal mechanism underlying
learning and memory processes. Consistent with SAMP8 mice,
alterations in LTP contribute to the deterioration of learning
and memory in single-transgenic (APP751SL), single-transgenic
(PS1M146L), double-transgenic (APP751SL/PS1M146L) (Gruart
et al., 2008) and triple-transgenic (PS1/M146V, APPSwe, and
tauP301L) mice (Garcia-Mesa et al., 2011).
These results showed that, by using the network analysis
method, the known cellular pathways were deeply elucidated
and the abnormal unknown biological pathways were predicted
in SAMP8 mice based on the sub-network, such as the ErbB
signaling pathway and focal adhesion.
SIGNIFICANT GENES IN THE BRAINS OF SAMP8 MICE
AD is a multifactorial complex disease, and both genetic vari-
ants and environmental factors contribute to this disease. The
genes more frequently related to AD include APP (Levy et al.,
1990; Goate et al., 1991; Goate, 2006), PS-1 (Sherrington et al.,
1995; Pantieri et al., 2005; Edwards-Lee et al., 2006; Müller
et al., 2013), PS-2 (Levy-Lahad et al., 1995a,b; Rogaev et al.,
1995), TREM2 (Guerreiro et al., 2013; Jonsson et al., 2013),
CLU, CR1 and PICALM (Harold et al., 2009; Carrasquillo et al.,
2010; Corneveaux et al., 2010; Jun et al., 2010; Barral et al.,
2012), ABCA7, MS4A4A/MS4A6E, EPHA1, CD33 and CD2AP
(Hollingworth et al., 2011; Naj et al., 2011), BIN1 (Lambert
et al., 2011; Lee et al., 2011; Wijsman et al., 2011), IL-12/IL-
23 (Vom Berg et al., 2012) and APOE (Bickeboller et al., 1997;
Elias-Sonnenschein et al., 2011; Genin et al., 2011; Verghese et al.,
2011).
Many studies on the differentially expressed genes have been
performed in SAMP8 mice, and these data are summarized by
Butterfield and Poon (Butterfield and Poon, 2005) and Tomobe
and Nomura (Tomobe and Nomura, 2009). Similar to senile
plaques, Aβ deposits are one of the pathological hallmarks of AD
and Aβ generated from APP in the amyloidogenic pathway. The
nucleotide sequence of APP in SAMP8 mice does not have muta-
tions similar to those that have been reported in human familial
AD (Kumar et al., 2001). The SAMP8 PS1 cDNA sequence is
identical to that of normal mice (Kumar et al., 2009). Using
the RNase protection assay, Morley et al. found an increase in
APP mRNA in the hippocampus of SAMP8 mice (Morley et al.,
2000). Using the RT-PCR technique, Wei et al. demonstrated that
the levels of PS-1 mRNA were normally expressed, while PS-
2 was significantly higher in the hippocampus of SAMP8 mice
compared with age-matched SAMR1 mice (Wei et al., 1999). In
the present study, we did not observe a change in the expres-
sion of App, PS-1 and PS-2 in the brains of SAMP8 mice using
cDNA microarray. Our results on APP and PS-2 mRNA expres-
sion were not consistent with those obtained by Wei et al. (1999)
and Morley et al. (2000), respectively, which may be due to the
methodological or short half-life of the two genes in SAMP8mice.
Additional, Lucas et al. identified the lack of DNA polymerase μ
in increased learning and brain LTP in aged mice, where brain
aging was delayed in Polμ−/− mice (Lucas et al., 2013). However,
we did not observe an increase in DNA polymerase μ mRNA in
SAMP8mice. This may be due to SAMP8mice not being a genetic
manipulation model. In this study, we observed 81 unique differ-
entially expressed genes in the hippocampus and cerebral cortex
of SAMP8 mice, including 78 genes in the hippocampus and 37
genes in the cerebral cortex.
The hub nodes (nodes with a very large number of direct inter-
acting neighbors) are thought to play an important role in bio-
logical networks (Jeong et al., 2001; Tew et al., 2007). The present
study identified 10 hub genes in the brain of SAMP8mice, includ-
ing RAF1 (Wang et al., 2003; Cheng et al., 2007b; Ponomarev
et al., 2007; Tseveleki et al., 2010), MAPT (Canudas et al., 2005),
PTGS2 (Hoozemans and O’Banion, 2005; Zhang et al., 2005; Ma
et al., 2008; Shi et al., 2010a), CDKN2A, CAMK2A, NTRK2,
AGER, ADRBK1 (Obrenovich et al., 2006; Cheng et al., 2007b;
Degos et al., 2013), MCM3AP and STUB1 (Cheng et al., 2007b;
Zhang et al., 2008) (Figure 6). These ten hub genes in SAMP8
mice were different from the genes more frequently related to
the AD patient. This may be due to SAMP8 mice being a spon-
taneous animal model and not a gene-modified model of AD.
Moreover, the phenotypes of SAMP8 mice resembled the symp-
toms of the late-onset and age-related sporadic AD patient (Pallas
et al., 2008). In these genes, we first identified the gene expression
of CDKN2A andMCM3AP, which were changed in SAMP8mice.
The present study showed cyclin-dependent kinase inhibitor
2A (CDKN2A) was down-regulated in the hippocampus of
SAMP8 mice. Zuchner and colleagues identified that CDKN2A
at 9p21 are implicated in the susceptibility in the late-onset AD
(Zuchner et al., 2008), but the role of CDKN2A genetic variants
in AD is not confirmed in late-onset patients based on Tedde
and colleagues’s (2011). Therefore, further studies are needed to
elucidate the role of tumor suppressor protein CDKN2A in the
susceptibility of AD.
The protein encoded by the gene minichromosome mainte-
nance complex component 3 associated protein (MCM3AP, also
known as GANP) is a minichromosome maintenance protein 3
(MCM3) binding protein. MCM3 is one of the MCM proteins
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essential for the initiation of DNA replication. MCM3 binding
protein was demonstrated to be an acetyltransferase that acety-
lates MCM3 and is an inhibitor of DNA replication initiation
(Takei et al., 2002, 2001). The present study showed MCM3AP
was down-regulated in the hippocampus of SAMP8 mice.
Calcium/calmodulin-dependent protein kinase II-alpha
(CAMK2A) is one of the most abundant subunits of the
calcium/calmodulin-dependent protein kinase II in the cerebral
cortex and hippocampus, is required for hippocampal LTP and
is closely linked to AD. Our previous study showed that the
levels of CAMK2A mRNA and protein were abnormal in the
hippocampus and cerebral cortex of SAMP8 mice (Cheng et al.,
2007b; Zhang et al., 2009). In addition, other data showed that
the CAMK2A-containing neurons were selectively lost in the
CA1 subfield of AD hippocampus and was accompanied with
enhanced CAMK2A in the remaining neurons. Approximately
33% hyperphosphorylated tau-containing neurons were also
immunoreactive for CAMK2A. Moreover, CAMK2A was largely
deposited in the senile plaques of the AD hippocampus (Wang
et al., 2005).
The NTRK2 gene encodes tropomyosin-related kinase B
(TrkB), a member of the neurotrophic tyrosine receptor kinase
(NTRK) family. TrkB is a membrane-bound receptor that, upon
neurotrophin binding, phosphorylates itself and members of
the MAPK pathway. BDNF-mediate activation of TrkB initi-
ates three major signaling pathway cascades: phospholipase C,
phosphatidylinositol 3-kinase (PI3K), and extracellular signal-
regulated kinase (ERK). Our previous data showed that the
mRNA expression of NTRK2 was up-regulated in the hippocam-
pus of SAMP8 mice (Cheng et al., 2007b). TrkB decreased in
the hippocampus and cerebral cortex early in the progression
of AD (Schindowski et al., 2008; Zuccato and Cattaneo, 2009),
and has a role in the pathogenesis of AD (Minichiello, 2009;
Nagahara et al., 2009; Devi and Ohno, 2012). Currently, the
dynamics of BDNF-TrkB signaling and its effect on the down-
stream signaling events during different forms of LTP are not
very well understood. However, an LTP-like increase in the hip-
pocampal synaptic responses was observed in behavioral mice
(Gruart et al., 2006), and blocking protein synthesis and BDNF
expression in the hippocampus caused a deficit in the persis-
tence of long-term memory (LTM) storage, but not in memory
formation (Bekinschtein et al., 2007). Moreover, the TrkB–PLCγ
site-activated molecular pathway underlies both associative learn-
ing and LTP, which was triggered at the CA3–CA1 hippocampal
synapse in behavioral mice (Minichiello et al., 2002; Gruart et al.,
2007).
The advanced glycosylation end product-specific receptor
(AGER) is a multiligand membrane receptor, and one of its lig-
ands is Aβ (Yan et al., 1996). AGER is the main factor mediating
Aβ cytotoxicity (Wan et al., 2013). AGER is a representative influx
transporter of APP or Aβin cerebral vessels, while low-density
lipoprotein receptor (LDLR) and LDL-related protein 1 (LRP1)
are efflux transporters. The present study showed that AGER was
down-regulated in the hippocampus of SAMP8mice. In addition,
other studies have shown that the gene and protein expressions of
RAGE were lower in SAMP8 brains compared to SAMR1 mice,
while LDLR was higher in SAMP8 brains compared to SAMR1
mice (Wu et al., 2009). In addition, it has been shown that sRAGE
is present at lower levels in the blood and brain of AD patients
(Emanuele et al., 2005; Nozaki et al., 2007).
IMPORTANT MicroRNAs IN THE BRAIN OF SAMP8 MICE
Based on the miRNA-gene bipartite graph network in the brain of
SAMP8 mice, we identified the top 10 miRNAs with P ≥ 8.37E-
05, including miR-20a, miR-17, miR-34a, miR-155, miR-18a,
miR-22, miR-26a, miR-101, miR-106b, and miR-125b (Table 3).
Many studies have indicated that these miRNAs played an impor-
tant role in AD by regulating the expression of specific genes.
In SAMP8 mice, these ten miRNAs might regulate the abnor-
mal expression of genes (nodes) in the genetic sub-network in the
brains of SAMP8 mice, and thereby results in the abnormalities
observed in the cellular function and malfunction of the biolog-
ical process. In these miRNAs, we first indicated that miR-34a,
miR-155, miR-18a, miR-22, miR-26a, miR-101, miR-106b, and
miR-125b were important in SAMP8 mice.
APP expression was regulated by miR-20a (Hebert et al.,
2009; Fan et al., 2010; Delay et al., 2011), miR-17 (miR-17-5p)
(Delay et al., 2011), miR-106b (Hebert et al., 2009), and miR-
101 (Vilardo et al., 2010; Long and Lahiri, 2011). In addition, a
tight correlation between miR-20a/miR-106b and APP was found
during brain development and in differentiating neurons (Hebert
et al., 2009). Moreover, the miR-17 and miR-20a bindings sites
located in or near the APP 3’UTR variants T117C, A454G and
A833C, and the A454G variant increased miR-20a binding (Delay
et al., 2011), and miR-17 and miR-20a were down-regulated in
age-related and senescence-related cellular processes (Hackl et al.,
2010).
MiR-34a has been shown to be a direct target of p53 (Chang
et al., 2007; He et al., 2007; Raver-Shapira et al., 2007) and
YY1, a negative regulator of p53 (Chen et al., 2011). In mice,
miR-34a is ubiquitous with the highest expression in the brain,
and overexpression of miR-34a in neuroblastoma cell lines mod-
ulates neuronal-specific genes (Wei et al., 2008; Chen et al.,
2011). MiR-34a regulates the expression of a number of synap-
tic proteins, in particular, synaptotagmin I and syntaxin 1A
in cortical neurons (Agostini et al., 2011). Moreover, miR-34a
was significantly up-regulated in sporadic AD subjects (Schipper
et al., 2007; Cogswell et al., 2008) and animal models (Li et al.,
2011).
MiR-155 is one of the most studied miRNAs and the first
miRNA to be described as oncogenic (Costinean et al., 2006).
MiR-155 was shown to participate in the regulation of immuno-
logical responses and apoptotic pathways (Park and Peter, 2008).
MiR-155 is thought to be essential in the pathogenesis of AD
according to induced down-regulation of complement factor-H
(CFH), an important repressor of the innate immune response
(Lukiw et al., 2012).
MiR-18a targets the protein inhibitor of activated STAT-3
(PIAS-3), an inhibitor of STAT-3 signaling (Brock et al., 2011),
and TNF-α induced protein 3 (TNFAIP-3), as the NF-κB path-
way inhibitor (Trenkmann et al., 2013), and ataxia telangiectasia
mutated (ATM) kinase, as the primary sensor and transducer of
DNA damage signal (Song et al., 2011). MiR-18a is involved in
the up-regulation of both the constitutive and TNF-α induced
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secretion ofMMP-1 and inflammatory cytokines and chemokines
(Trenkmann et al., 2013).
MiR-22 targets the pro-apoptotic activities of mitogen-
activated protein kinase 14/p38 (MAPK14/p38) and tumor pro-
tein p53-inducible nuclear protein 1 (Tp53inp1). Overexpression
of miR-22 decreased neurodegeneration in an in vitro model
(Jovicic et al., 2013). In addition, miR 22 regulates the cell cycle
length in cerebellar granular neuron precursors (Berenguer et al.,
2013).
MiR 26a targets phosphatase and tensin homolog (PTEN) (Liu
et al., 2012; Li and Sun, 2013). The number and distribution of
neurites was markedly increased by miR-26a, and inhibition of
miR-26a functioned in attenuated neuronal outgrowth (Li and
Sun, 2013).
MiR-125b is involved in the targeting and down-regulation
of complement factor-H (CFH) mRNA and CFH expression.
MiR-125b was significantly found to be up-regulated in AD
brain tissues (Lukiw, 2007; Lukiw and Pogue, 2007; Lukiw and
Alexandrov, 2012), and it was proposed to be involved in driven
pathogenic signaling in neurodegenerative diseases, including
human prion disease and Down’s syndrome (Wang et al., 2010;
Lukiw and Alexandrov, 2012).
In addition, it was reported that miR-101 regulates ataxin1
expression in the hippocampus (Lee et al., 2008). MiR-106b
significantly decreased the ATP-binding cassette transporter A1
(ABCA1) levels and impaired cellular cholesterol efflux in neu-
ronal cells (Kim et al., 2012), targets TGF-β type II receptor
(TβR II) to affect TGF-β signaling, thereby contributing to the
pathogenesis of AD (Wang et al., 2010).
Taken together, aberrations in the normal cellular function
and malfunction of biological process were caused by hub genes
and their regulated miRNAs disrupt the fine-tuning of genetic
networks and caused the AD-like phenotype in SAMP8 mice.
CONCLUSIONS
In summary, in this study, we provided a systems biologi-
cal interpretation of the molecular underpinnings of SAMP8
mice as an AD animal model based on network analysis.
Biological processes, including the regulation of synaptic trans-
mission and apoptosis, were clearly identified as disrupted in
the brains of SAMP8 mice. The abnormal expression of gene
RAF1, MAPT, PTGS2, CDKN2A, CAMK2A, NTRK2, AGER,
ADRBK1, MCM3AP, and STUB1 might be the key cause
to the malfunction of biological processes in the brains of
SAMP8 mice. In addition, microRNAs, including miR-20a,
miR-17, miR-34a, miR-155, miR-18a, miR-22, miR-26a, miR-
101, miR-106b, and miR-125b might regulate the expression
of genes (nodes) in the sub-network, thereby disrupting the
fine-tuning of genetic networks in SAMP8 mice. These results
provide new insights into the biological and genetic mecha-
nisms of SAMP8 mice, and add an important dimension to
our understanding of the neuropathogenesis in SAMP8 mice
from a systems perspective. Moreover, in the extraordinary cel-
lular pathways of the gene involved, we first indicated that the
ErbB signaling pathway and focal adhesion in SAMP8 mice
were abnormal. Furthermore, the gene expression of CDKN2A
and MCM3AP were changed, and miRNAs, including miR-
34a, miR-155, miR-18a, miR-22, miR-26a, miR-101, miR-106b,
and miR-125b are important in SAMP8 mice in the present
study.
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